PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 7, 2026Journal of the American College of Cardiology614 citations

2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

View Full Paper
CYClyde W. YancyMJMariell JessupBBBiykem Bozkurt

Key Points

  • This update aims to provide recent guidance on pharmacological treatments for heart failure.
  • Review of new therapies and their implications for heart failure management.
  • Comparison with previous guidelines from 2013.
  • Expert consensus on best practices.
  • Introduction of new drugs shown to improve heart failure outcomes.
  • Revised recommendations for existing therapies based on recent clinical trials.
  • Emphasis on personalized treatment approaches.

Abstract

No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.

Expert Takes5 quotes

1/5

“Not every patient is a good candidate for every drug; these guidelines can help physicians decide who best fits which treatment. This document details the benefits and risks of these new therapies so that patients at high risk can be directed toward alternative therapies.”

Clyde W. Yancy, Chief of cardiology, Northwestern University Feinberg School of Medicineauto_pipelineSupportiveView source
Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yancy et al. (2016) studied this question.

synapsesocial.com/papers/6a258be5574e690f5ca04d0chttps://doi.org/10.1016/j.jacc.2016.05.011
Ask AI
Helpful
Bookmark
Share
View Full Paper